Candel Therapeutics: Navigating Stock Volatility with Innovative Cancer Therapies
Candel Therapeutics, a biopharmaceutical company, is navigating a volatile market with its oncolytic viral immunotherapies, but its innovative approach holds promise for revolutionizing cancer treatment.
3 minutes to read